Characterization of the rat transforming growth factor alpha gene and identification of promoter sequences. by Blasband, A J et al.
MOLECULAR AND CELLULAR BIOLOGY, May 1990, p. 2111-2121 Vol. 10, No. 5
0270-7306/90/052111-11$02.00/0
Copyright X) 1990, American Society for Microbiology
Characterization of the Rat Transforming Growth Factor Alpha
Gene and Identification of Promoter Sequences
ANDREW J. BLASBAND,1t KATHLEEN T. ROGERS 2f XIAORONG CHEN,2 JANE C. AZIZKHAN,1,3'4
AND'DAVID C. LEE' 2*
Lineberger Cancer Research Centerl* and Departments of Microbiology and Immunology,2 Pediatrics,3 and
Pharmacology,4 University of North Carolina at Chapel Hill, North Carolina 27599-7295
Received 1 November 1989/Accepted 5 January 1990
We have determined the complete nucleotide sequence of rat transforming growth factor a (TGFa) mRNA
and characterized the six exons that encode this transcript. These six exons span approximately 85 kilobases of
genomic DNA, with exons 1 to 3 separated by particularly large introns. What had previously been thought to
represent a species-specific difference in the size of the TGFa precursor (proTGFa) is now shown to be due to
microheterogeneity in the splicing of exons 2 and 3. This results from a tandem duplication of the acceptor CAG
and gives rise to two alternate forms (159 and 160 amino acids) of the integral membrane precursor. Exon 6,
which encodes the 3' untranslated region of TGFa mRNA, also encodes, on the opposite strand, a small
(approximately 200-nucleotide) transcript whose sequence predicts an open reading frame of 51 amino acids.
Expression of this latter transcript does not appear to be coregulated with that of TGFa mRNA. Primer
extension and Si nuclease analyses of authentic TGFa transcripts revealed two major and multiple minor 5'
ends which span more than 200 base pairs ofDNA in a G+C-rich region that lacks canonical CCAAT or TATA
sequences. The 5' ends of six independently derived cDNAs localized to five different sites in this same region.
Restriction fragments that overlap these transcription start sites and extend approximately 300 base pairs in the
5' direction faithfully promote transcription in vitro with HeLa cell nuclear extracts. In addition, they direct
the expression of the bacterial chloramphenicol acetyltransferase gene in transient-transfection assays.
Transforming growth factor alpha (TGFa) is an epidermal
growth factor-related mitogenic polypeptide that is synthe-
sized as a transmembrane glycoprotein precursor of 159 or
160 amino acids (termed proTGFa) (8, 26). The external
domain of proTGFa is processed at alanine/valine cleavage
sites by an enzyme(s) whose activity is mimicked by pan-
creatic elastase (15). Complete cleavage results in the release
of the 50-amino-acid mitogen that was first identified in the
culture fluids of retrovirus-transformed and chemically
transformed cells (30). However, cleavage is incomplete in
many transformed cells, resulting in the accumulation of
proTGFa at the cell surface (4), as well as in the release of
larger, heterogeneously glycosylated forms due to selective
cleavage at the carboxy-alanine/valine site (5, 15, 29, 41).
The larger secreted forms of TGFa are also mitogenic (15),
and recent studies have shown that proTGFa anchored to
the cell membrane can bind to EGF/TGFa receptor on
adjacent cells, thereby activating the intrinsic tyrosine ki-
nase activity of the receptor (4, 46). These various observa-
tions suggest that the fully processed, 50-amino-acid mole-
cule is not the only physiologically important form of this
growth factor.
Although TGFa protein and/or mRNA has been detected
in a variety of normal tissues including pituitary (38), skin
(6), decidua (14), and brain (25, 45) tissue, expression of this
mitogen is distinguished by the fact that it is frequently
induced or enhanced by neoplastic transformation. Thus,
TGFa mRNA and protein are most prevalent and abundant
in tumor cells (1, 7, 47) and cells transformed by retrovi-
ruses, oncogenes, and chemicals (10, 27, 37; J. W. Grisham,
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M.-S. Tsao, D. C. Lee, and H. S. Earp, Pathobiology, in
press). The expression of TGFa in both normal and neoplas-
tic cells can also be regulated by defined agents. For exam-
ple, estrogen treatment of primary differentiated rat mam-
mary tumor cells in culture leads to both elevated expression
ofTGFa mRNA and increased secretion of the growth factor
into the culture medium (9, 28). In addition, expression of
this growth factor can also be regulated in a protein kinase
C-dependent manner. Hence, the levels ofTGFa mRNA are
significantly induced by both the tumor promoter 12-0-
tetradecanoylphorbol-13-acetate and epidermal growth fac-
tor in a chemically transformed rat liver epithelial cell line
(GP6ac) (36), in cells of the bovine anterior pituitary gland
(31), and in human keratinocytes (6, 34). The transient
induction by TPA, which in GP6ac cells is at least partly due
to increased transcription of the TGFa gene (36), may be
distinguished from that of other transcripts including c-myc
(20) and c-fos (24, 32) by both the time course of induction
and the sensitivity to inhibition of protein synthesis (36).
However, the molecular mechanism(s) responsible for either
this induction or the transformation-linked enhancement of
expression is unknown.
The finding that TGFa activity is elevated in many neo-
plastic cells as well as in human cancer patients (1, 47),
together with the presumed role of TGFa in autocrine
growth regulation, underscores the importance of defining
the molecular regulation of its expression. A critical step in
this process is the characterization of the gene and its
promoter. A preliminary description of the human TGFa
promoter was recently published (17). Here we extend this
observation by presenting the complete nucleotide sequence
of the rat TGFa transcript, as well as the intron-exon
structure of the gene. In addition, we present a partial
characterization of the rat promoter, which, in apparent
contrast to its human counterpart, directs transcription
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from numerous sites spanning almost 250 base pairs of
DNA.
MATERIALS AND METHODS
Cells and reagents. JM1 cells are rat hepatocellular carci-
noma cells that were clonally derived from a chemically
induced liver tumor (33). GP6ac and GP6TB cells are trans-
formed cells that were clonally derived from a chemically
transformed normal rat liver epithelial cell line, WB-FB344
(12, 43, 44). The GP6ac line was selected for growth in soft
agar in the absence of exogenous growth factors. The
GP6TB line was derived from a tumor produced in neonatal
syngeneic rats. Each of the above cell lines was maintained
in monolayer in Richter's minimal essential medium supple-
mented with 10% fetal bovine serum. Poly(A)+ RNA was
isolated from cells and tissues as described previously (14).
Oligonucleotide probes and primers were synthesized by
using a DNA synthesizer (no. 380B; Applied Biosystems,
Inc., Foster City, Calif.).
Cloning of genomic and complementary DNAs. High-mo-
lecular-weight DNA was prepared from the liver of a normal
Sprague-Dawley rat as described previously (3) and judged
to be >150 kilobase pairs (kb) in size by analysis on a 0.3%
agarose gel. For construction of the cosmid library, DNA
was partially digested with MboI and fractionated on 10 to
40% sucrose gradients, and fragments of approximately 50
kb were pooled and precipitated with ethanol. Size-fraction-
ated DNA was ligated to cosmid vector pWE-15 DNA
(Stratagene Inc., La Jolla, Calif.) that had been previously
digested with BamHI and treated with calf intestinal phos-
phatase (Boehringer Mannheim Biochemicals, Indianapolis,
Ind.). Ligation reactions were packaged in vitro by using
Gigapak Gold extracts (Stratagene) and used to infect Esch-
erichia coli 1046. The resulting cosmid library, which con-
sisted of approximately 500,000 CFU with an average insert
size of 40 kb, was plated and screened as previously de-
scribed (40). Walking was accomplished by using end-spe-
cific, single-stranded RNA probes derived from the flanking
SP6 and T7 promoters of pWE-15 as recommended by the
manufacturer.
For construction of lambda libraries, genomic DNA was
digested with either EcoRI, HindlII, or XbaI, and fragments
ranging from 10 to 20 kb in size were purified from a
low-melting-point agarose (Bio-Rad Laboratories, Rich-
mond, Calif.) gel. Size-fractionated DNA was ligated to
lambda (Charon 35) arms and packaged as described above.
A library of partially digested EcoRI fragments of rat ge-
nomic DNA in lambda (Charon 4) was purchased from
Clonetech, Palo Alto, Calif. Lambda libraries were screened
with either 32P-labeled, nick-translated restriction fragments
or end-labeled oligonucleotides.
cDNAs were synthesized by using either oligo(dT) or
specific oligonucleotide primers and inserted into the EcoRI
site of lambda gtlO by using EcoRI linkers as previously
described (26). Clones containing TGFa cDNAs were iden-
tified as described above.
DNA sequence analysis. Genomic fragments and cDNAs
were sequenced as double-stranded templates by the dide-
oxy-chain termination method of Sanger et al. (39) with
[a-32P]dCTP (Du Pont, NEN Research Products, Boston,
Mass.) and T7 DNA polymerase (U.S. Biochemical Corp.,
Cleveland, Ohio). In all cases, the nucleotide sequence of
overlapping regions was determined on both strands by
using specific oligonucleotide primers.
Analysis of TGFa mRNA 5' ends. TGFa mRNA 5' ends
were analyzed by using oligonucleotide primers that were 39
residues long. Primers were end labeled to high specific
activity with T4 polynucleotide kinase and [.y-32P]ATP (Du
Pont, NEN). For primer extension reactions, labeled primer
(105 cpm) was hybridized to 10 ,ug of poly(A)+ RNA for 18 h
at 42°C in 50% formamide-40 mM piperazine-N,N'-bis(2-
ethanesulfonic acid) (PIPES; pH 6.4)-400 mM NaCl-1 mM
EDTA (pH 8.0). After ethanol precipitation, annealed primer
was extended with avian myeloblastosis virus reverse tran-
scriptase (U.S. Biochemical) as described previously (22).
Samples were treated with pancreatic RNase (1 ,ug/ml) for 30
min at 37°C, extracted with phenol-chloroform, ethanol
precipitated, and electrophoresed on a 6% polyacrylamide-8
M urea gel in 1 x TBE (89 mM Tris, 89 mM boric acid, 2 mM
EDTA). The dried gel was exposed to X-ray film overnight at
-700C.
S1 nuclease analysis was carried out essentially as de-
scribed previously (13). Briefly, end-labeled primer was
annealed to denatured EcoRIIXbaI-CAT plasmid (see Fig.
4B) and then extended by using the Klenow fragment of E.
coli DNA polymerase I. The extension product was digested
with Hindlll, and the single-stranded probe was isolated by
electrophoresis on a low-melting-point alkaline agarose gel.
Probe (5 x 104 cpm) was hybridized to 10 ,ug of poly(A)+
RNA overnight at 420C in a buffer containing 50% formamide
as described above. After ethanol precipitation, samples
were digested with S1 nuclease (Bethesda Research Labo-
ratories, Inc., Gaithersburg, Md.), reprecipitated with etha-
nol, and analyzed by electrophoresis on a 6% polyacryl-
amide-8 M urea gel as described above.
Assays for transient expression of TGFa-CAT constructs.
Subconfluent GP6ac cells were harvested by trypsinization,
suspended in RPMI 1640 medium containing 10% fetal
bovine serum, and transfected with TGFa-chloramphenicol
acetyltransferase (CAT) constructs by electroporation. Plas-
mid DNA (10 pug; purified by two sequential cesium chloride
centrifugations) was transfected into 107 cells in 0.5 ml of
RPMI medium-10% fetal bovine serum at 1,650 volts by
using a Zapper electroporation unit from the University of
Wisconsin Medical Electronics Shop. Transfected cells were
plated in Richter's minimal essential medium-10% fetal
bovine serum and 48 h later an extract of the cells was
prepared and incubated for 3 h at 37°C with ['4C]chloram-
phenicol in the presence of acetyl coenzyme A, as described
previously (21). The percent acetylation of chloramphenicol
was quantitated by thin-layer chromatography followed by
autoradiography and scintillation counting.
In vitro transcription. Nuclear extracts were prepared
from HeLa-S3 cells as previously described (2, 11). In vitro
transcription reactions were performed in a final volume of
25 tl containing 400 ,uM each ATP, CTP, and UTP, 50 ,uM
[a-"P]GTP (3,000 Ci/mmol; 10 ,uCi per reaction; Du Pont,
NEN), 1 mM creatine phosphate, and 140 ,uM EDTA.
Transcription reactions were initiated by the addition of
linearized plasmid template DNA and 15 pd of nuclear
extract (150 ,ug of protein). The reactions were incubated at
300C for 60 min, and stopped by the addition of a mixture
containing 8 M urea, 0.5% sodium dodecyl sulfate, 10 mM
EDTA, and 10 mM Tris (pH 8.0). A 494-nucleotide Sp6
transcript was included in the stop mixture as a control for
sample recovery during processing. The samples were phe-
nol-chloroform extracted twice, ethanol precipitated, and
electrophoresed on a 4% polyacrylamide-7 M urea gel in
0.5x TBE. The gel was exposed to X-ray film overnight at
-70°C with an intensifying screen. Reactions were also
carried out in the absence of radioactive label, and after
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phenol-chloroform extraction and ethanol precipitation the
purified RNA was used as a template for primer extension
reactions.
RESULTS AND DISCUSSION
Nucleotide sequence of rat TGFa cDNA. The 2.3-kb rat
TGFa cDNA originally isolated (3Blb [26]) was only a
partial copy of the approximately 4.5-kb mRNA. To obtain a
full-length transcript, we constructed an oligo(dT)-primed
cDNA library in AgtlO by using poly(A)+ RNA from a
chemically transformed rat liver epithelial cell line (GP6TB)
that expressed relatively high levels of TGFa mRNA (Gris-
ham et al., in press) (see Fig. 4A). The library was screened
by using the original cDNA as a hybridization probe, and a
XgtlO clone that contained EcoRI fragments of 3.2 and 1.1 kb
was identified. These fragments were subcloned into the
plasmid vector pEMBL and sequenced on both strands by
using the dideoxy-chain termination method and specific
oligonucleotide primers. The nucleotide sequence of the
3.2-kb insert (designated 22A3) predicted an open reading
frame that was identical to that previously established for rat
proTGFa (26), and this reading frame then determined the
orientation of the insert. The sequence at the 5' end of the
3.2-kb fragment was consistent with the addition of a syn-
thetic EcoRI linker; the apparent 5' end of the actual cDNA
was found to be identical to that of the original, 3Blb cDNA.
The sequence of the 3.2-kb insert extended approximately 1
kb beyond the poly(A)+ addition site of 3Blb and terminated
at an apparently natural EcoRI site.
The 1.1-kb cDNA insert (designated 22A1) was found to
contain, at one end, an EcoRI linker sequence followed by a
poly(A-T) tract of 60 residues and, at the other, an appar-
ently natural EcoRI site. We presumed that the poly(A-T)
tract defined the 3' end of this insert and that the 3.2- and
1.1-kb inserts joined by the natural EcoRI site corresponded
to an essentially full-length copy of the roughly 4.5-kb TGFa
mRNA. This hypothesis was corroborated by the findings
that (i) both the 3.2- and 1.1-kb inserts hybridized to a 4.5-kb
transcript on Northern (RNA) blots (data not shown) and (ii)
the sequences contained at the 3' and 5' termini of these
fragments are contiguous in genomic DNA (exon 6; see Fig.
2) and flank an EcoRI site (data not shown). Thus, the
original cDNA clone, 3Blb, apparently corresponds to a
transcript that is polyadenylated at a more 5' site than is the
4.5-kb mRNA. It may correspond to a 2.3- to 2.5-kb species
that is variably observed on Northern blots of tissue and cell
RNAs, but is always present at significantly lower abun-
dance than the 4.5-kb transcript.
A composite nucleotide sequence of the rat TGFa cDNA
as deduced from the 3.2- and 1.1-kb inserts is presented in
Fig. 1A. The transcript (whose structure is presented sche-
matically in Fig. 1B) is marked by the presence of a short,
G+C-rich 5' untranslated region of approximately 150 nu-
cleotides and a long 3' untranslated sequence of roughly
3,600 nucleotides. The latter region contains a CA repeat,
which immediately follows the aforementioned EcoRI site. It
also contains, near the 3' end, multiple (AIG)T"(AIG) tracts,
including several ATTTA motifs which have been implicated
in regulating mRNA stability.
Characterization of the rat TGFa gene. To characterize the
organization of the rat TGFa gene, we first identified ge-
nomic EcoRI fragments of 10 and 3 kb that hybridized to 3'
untranslated-region probes derived from the 3.2- and 1.1-kb
cDNAs, respectively. We then walked in the 5' direction,
using specific oligonucleotide probes to identify additional
exons. Our initial walking was carried out with lambda
libraries of partial or size-fractionated restriction fragments.
Owing to the relatively large size of the gene, however, we
subsequently constructed a cosmid library of overlapping 40-
to 50-kb fragments obtained by partial MboI digestion. In
this way, we identified six exons which span approximately
85 kb of genomic DNA (Fig. 2) and which together account
for all of the sequence contained in the full-length TGFa
transcript. Exon 1 encodes the 5' untranslated region and the
NH2-terminal portion of the signal peptide. The remainder of
the signal peptide is encoded by exon 2. Exon 3 encodes the
first two disulfide loops of the mature, 50-amino-acid growth
factor, and exon 4 encodes the third disulfide loop and
transmembrane domains. Exon 5 encodes the cytoplasmic
portion of proTGFa, and exon 6 comprises the entire 3'
untranslated region.
The intron-exon junction sequences are shown in Table 1.
An examination of the intron sequence that immediately
precedes exon 3 revealed that the donor CAG triplet is
tandemly duplicated. This suggested that alternate splicing
could result in the generation of two mature transcripts, the
longer of which would contain an additional alanine residue
at position 32 (relative to the initiating methionine) and
presumably correspond to the cDNA cloned from a human
renal-cell carcinoma (8). This suggestion was corroborated
by the finding of cDNAs corresponding to both transcripts in
the library constructed from GP6TB cells (data not shown).
Thus, both 159- and 160-amino-acid forms of proTGFa are
apparently synthesized in rat cells, although there is cur-
rently no evidence to suggest a functional distinction be-
tween these two forms of the molecule.
When used as a hybridization probe in Northern blot
analysis, the original rat TGFa cDNA clone (3Blb) fre-
quently detects, in addition to the 4.5-kb mRNA, a small
transcript of approximately 0.2 kb. Using a variety of sense
and antisense probes, we localized the sequences corre-
sponding to this transcript to a 350-base-pair fragment that is
immediately 5' to the first polyadenylation site on the
opposite strand from that of the TGFa coding frame (data
not shown) (Fig. 1). As determined for the original 3Blb
cDNA, as well as a genomic fragment, the nucleotide
sequence of this region predicts a single open reading frame
of 51 amino acids. However, the full-length 22A3 cDNA
shown in Fig. 1 contains a 9-base-pair substitution within
this region, with an AAGCAGGAG sequence being replaced
by the sequence GAGCATGCA. This not only results in the
substitution of a Lys-Gln-Glu tripeptide with a Glu-His-Ala
sequence at positions 3 to 5 of the putative protein, but also
creates an alternate reading frame of 45 amino acids begin-
ning at position +11 relative to the aforementioned ATG.
Since the ATG of this alternate reading frame is 3' distal to
the first and is not present in our genomic clone or in the
3Blb cDNA isolated from feline sarcoma virus-transformed
Fischer rat embryo fibroblasts, we hypothesize that the
0.2-kb transcript encodes the 51-amino-acid protein de-
scribed above. This putative protein contains an unusual
stretch of asparagine residues and two potential overlapping
glycosylation sites (Fig. 3A).
A small (350-base-pair) transcript was recently shown to
be expressed from the antisense strand of the human TGFa
gene (18). This transcript, which was broadly mapped to the
3' untranslated region, was found to be expressed in an
inverse manner with respect to that of TGFa mRNA. In
contrast, expression of the 0.2-kb transcript in rat cells is not
obviously coregulated in either a positive or negative manner
with that of TGFa mRNA. Thus, the 0.2-kb transcript is
VOL. 10, 1990
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FIG. 1. (A) Complete nucleotide sequence of a full-length rat TGFa cDNA. The predicted sequence of the 159-amino-acid precursor is
shown, and the portion corresponding to the mature, secreted 50-amino-acid growth factor is delineated by a heavy underline. The two
predicted polyadenylation signals in the 3' untranslated region are underlined, and an alternate site of polyadenylation observed with a
previously isolated cDNA (26) is indicated (V). The presence of a CACA repeat is marked by a broken underline, and the location of an open
reading frame that is encoded by a small transcript expressed from the opposite DNA strand in exon 6 (see text and Fig. 2) is indicated by
arrows. This sequence will appear in the EMBL, GenBank, and DDBJ nucleotide sequence data bases under the accession number M31076.
(B) Partial restriction map of the 4.5-kb rat TGFa cDNA. Symbols: , position of sequences that encode the precursor; _, position of
the mature, 50-amino-acid growth factor within those sequences. The poly(dA-dT) tract at the 3' end is indicated.
expressed in many rat tissues and cell lines, including those
that express TGFa mRNA at both high and low levels (data
not shown). In addition, unlike that ofTGFa mRNA, expres-
sion of the smaller transcript is not appreciably induced in a
transformed rat liver epithelial cell line, GP6ac, 8 h after the
addition of 100 nM TPA to the medium (Fig. 3B). That the
0.2-kb transcript is polyadenylated is suggested by the finding
that its detection is enhanced in oligo(dT)-purified RNA
derived from a rat hepatocellular carcinoma line (JM1), as
well as from the cervical spinal cord, a site of relatively high
TGFa mRNA expression in the normal adult rat (Fig. 3B).
Analysis of TGFa mRNA 5' ends. In the course of screen-
ing the oligo(dT)-primed cDNA library, we characterized the
5' ends of three TGFa cDNAs that appeared, on the basis of
size, to be essentially full-length. The 5' ends of these
cDNAs mapped to three different positions within 75 bases
upstream from the 3Blb/22A3 5' end (see Fig. 7). Addition-
ally, we constructed a second cDNA library from GP6TB
RNA by using a specific primer that was designed to
hybridize to the 5' untranslated region of TGFa mRNA,
immediately upstream from the initiating ATG. Screening of
this library with oligonucleotide probes corresponding to the
5' untranslated sequence failed to yield any clones larger
than 250 base pairs in length (data not shown). The 5' end of
the longest clone mapped to a position 115 nucleotides
upstream from the common 3Blb/22A3 5' end (see Fig. 7).
The above findings suggest that rat TGFa mRNA com-
prises a collection of transcripts with heterogeneous 5' ends.
cDNA
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FIG. 2. Exon-intron structure of the rat TGFa gene. The functional domains of the rat TGFot mRNA, as deduced from the cloned cDNA,
are indicated together with the exon organization as revealed by sequence analysis. The approximate locations of these exons (bars) in
overlapping cosmid (a and b) and X (c) genomic clones are indicated. The positions of EcoRI sites are marked by vertical lines. A complete
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TABLE 1. Intron/exon junction sequences
Nucleotide sequence and predicted amino acid sequence'
Ala Leu
..... GCG CTG G gtacgtagg
Gly Ile Ser




















acctcttttttttctgtctgacag TG GTC TGA A.....
(py)lon(c/t)agG .. Exon .... AG gt(a/g)gt
a The nucleotide sequences flanking the intron/exon junctions of the rat TGFa gene are indicated along with predicted amino acid sequence. The intron
sequence is indicated by lower case letters, and the exon sequence is indicated by capital letters. Splice acceptor and donor sequences are underlined.
To directly address this possibility, we carried out primer
extension and Si nuclease analyses of poly(A)+ RNA from
two rat cell lines, GP6TB and JM1, that express TGFa
mRNA at relatively high levels (Fig. 4A). Primer extension
was carried out with two different oligonucleotide primers,
RT1 and RT3. RT1 spans sequences present in exons 1 and
2 and is the more distal primer, whereas RT3 is complemen-
tary to sequences wholly contained in exon 1, beginning 41
nucleotides downstream from the 3B1b/22A3 5' end (Fig.
4B). When RT1 was used for primer extension with poly(A)+
RNA from GP6TB cells, we observed a predominant band of
approximately 112 nucleotides, along with a more distal
cluster of products ranging in size from 230 to 330 nucleo-
tides (Fig. 4C, lane 2; see also Fig. 6B). Within this cluster
was a predominant transcript(s) of approximately 244 bases.
A similar pattern of upstream products was observed when
RT3 (which is upstream from, and therefore does not detect,
the aforementioned 112-base product) was used as the
primer. Thus, RT3-primed extension of both GP6TB and
JM1 RNAs yielded a large number of products ranging from
100 to more than 200 bases in length, with predominant
bands of approximately 86 to 88 nucleotides. None of these
products were observed when the RT1- and RT3-primed
extensions were carried out by using poly(A)+ RNA from
either normal rat liver (Fig. 4C, lanes 2 and 3) or a nontrans-
formed rat liver epithelial cell line, WB-F344 (27) (data not
shown), neither of which expresses TGFa mRNA at appre-
ciable levels.
To confirm that the many distal primer extension products
described above correspond to authentic 5' ends, we used an
EcoRI-XbaI subclone of the rat genomic sequences to ana-
lyze endogenous GP6TB RNA by Si nuclease protection
analysis. End-labeled RT3 was annealed to the denatured
subclone and extended by using the Klenow fragment of
DNA polymerase I. After digestion with HindIll, a single-
stranded, 505-nucleotide probe (Fig. 4B) was isolated from a
denaturing alkaline agarose gel. Hybridization of this probe
to GP6TB poly(A)+ RNA yielded an essentially indistin-
guishable pattern of Si nuclease-resistant bands to that
obtained by primer extension with RT3 (Fig. 4C, compare
lanes 6 and 8). As in the case of the extension products,
these Si-resistant bands were not observed with normal rat
A
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FIG. 3. (A) Predicted amino acid sequence of an antisense
transcript. This open reading frame is encoded by a small transcript
that is expressed from the opposite strand to that of TGFa in exon
6. The position of this open reading frame is illustrated relative to
the TGFa 3' untranslated sequence in Fig. 1A. An asparagine repeat
is underlined, and two overlapping glycosylation consensus sites are
boxed. (B) Expression of the antisense transcript. Northern blots of
total (lanes 1 to 4) or poly(A)+ (lanes 5 and 6) RNA (10 ,ug per lane)
probed with the cloned 2.3-kb rat TGFa cDNA (26). GP6ac cells
were treated with 100 nM TPA for 0, 1, 2, or 8 h prior to harvest.
RNAs were prepared and analyzed as previously described (14).
The approximate sizes of the observed transcripts, as judged by
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liver poly(A)+ RNA. Although we have not confirmed the
proximal 5' end (the 112-nucleotide product referred to
above) by Si nuclease analysis, its authenticity is confirmed
by the results of in vitro transcription studies described
below. Together with the primer extension data, these
results indicate the absence of intervening sequences 5' to
the initiation codon, and demonstrate multiple 5' start sites
spanning a distance of more than 200 base pairs. Calculating
for the positions of the primers, predominant 5' ends are
found 58 and 188 to 190 nucleotides upstream from the
initiating codon, but minor 5' ends extend to almost 300
nucleotides (see Fig. 7). This is in contrast to a recent report
describing a single 5' end for the human TGFa mRNA that is
62 nucleotides 5' of the initiating codon (17). The latter
appears to be in an analogous position to that of the
predominant 5' end noted at position -58 (see above).
Characterization of promoter activity. To determine wheth-
er the DNA sequences that flank the 5' ends of rat TGFa
mRNA have promoter activity, we constructed a series of
vectors that placed the bacterial CAT gene adjacent to
various genomic fragments (Fig. SA). These genomic frag-
ments contain variable amounts of 5' sequence but end with
a common 3' terminus at the BssHII site (see Fig. 7). The
latter was chosen to exclude the TGFa translational initia-
tion codon. Promoter activity was then assayed indirectly by
measuring CAT activity in cell extracts prepared 48 h after
electroporation of vectors into the chemically transformed
GP6ac cell line. The results (Fig. SB) demonstrate that
vectors containing the 410-base-pair HindIII-BssHII and
480-base-pair SmaI-BssHII fragments displayed measurable
promoter activity in this transient-expression assay, al-
though in both cases the activity observed was lower than
that obtained with pSV2-CAT. In contrast, the inclusion of
additional upstream genomic sequence reduced the CAT
activity to a level equal to or lower than that observed with
the promoterless pUC-CAT vector. The latter appears to
direct a low level of transcription from a cryptic promoter
within vector sequences. Thus, both the 680-base-pair NheI-
BssHII fragment and 1,900-base-pair EcoRI fragment lacked
demonstrable promoter activity, raising the possibility of
upstream transcriptional repressorlike sequences. Finally, it
should be noted that the experiment shown in Fig. 5 was
repeated several times in both GP6ac and other transformed
rodent and human cell lines, with analogous results (data not
shown).
The potential promoter activity of the immediate upstream
flanking sequences has also been tested by assaying their
ability to direct transcription in vitro. The HindIII-XbaI




1 2 3 45 6 7 8
FIG. 4. 5'-End analysis of endogenous rat TGFa mRNA. (A)
Expression of rat TGFa mRNA. Northern blot analysis of poly(A)+
RNA (10 ,ug per lane) probed with the cloned 2.3-kb rat TGFa
cDNA (26). RNAs were prepared from liver and JM1 and GP6TB
cell lines as previously described (14). The position of the 4.5-kb
TGFa transcript is indicated. (B) Preparation of primer extension
and Si nuclease probes. A partial restriction map of genomic DNA
at the 5' end of the rat TGFa gene is shown. The approximate
locations of cDNA 5' ends are marked (*), and the extent of exon 1
is indicated by the heavy line. The approximate positions of the RT1
and RT3 primers are illustrated, along with the structure of the Si
nuclease probe. (C) Primer extension and S1 nuclease analyses of
endogenous TGFa transcripts. RT1 and RT3 primers were hybrid-
ized to 10 jig of rat poly(A)+ RNA from either liver or GP6TB or
JM1 cell lines. The Si nuclease probe was generated by using the
RT3 primer and hybridized to 10 jig of poly(A)+ RNA from liver or
GP6TB cells. The positions of Hinfl-cut pBR322 markers are indi-
cated, although the primer extension and S1 nuclease products were
actually sized with reference to either RT1- or RT3-primed dideoxy
sequencing reactions included on the same 6% polyacrylamide-urea
gels (not shown). The extended arrow and asterisks indicate the
relative positions of RT1- and RT3-primed extension products, re-
spectively, that appear to share the same 5' terminus. Note that the
primer extension and Si nuclease products in experiment 2 were
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FIG. 5. Transient expression of TGFa-CAT constructs. (A) Par-
tial restriction map of genomic DNA at the 5' end of the rat TGFa
gene. Exon 1 is shown (_), and the position of the translational
initiating ATG is indicated. The construction of chimeric TGFa-
CAT plasmids is illustrated, and the extent of genomic sequence
inserted before the CAT gene is indicated. Arrows designate the
direction of transcription. bp, Base pairs. (B) GP6ac cells were
electroporated with 10 p.g of plasmid DNA and, after 48 h, harvested
for determination of CAT activity as described in Materials and
Methods. pUC-CAT is the parental promoterless construct, and
pSV2-CAT contains the simian virus 40 early promoter. The percent
acetylation was determined by counting the relevant portions of the
thin-layer chromatography plate in liquid scintillant.
and extends into intron 1 of the TGFa gene, was subcloned
into the pBluescript vector (Stratagene), and the resulting
recombinant plasmid was digested with either SspI or
DraIII. These linearized DNAs were then tested for their
ability to direct specific transcription in runoff assays in the
presence of nuclear extracts (2, 11) derived from trans-
formed human HeLa cells. Since the SspI cleavage site is
more distal to the HindIII-XbaI insert than is the DralIl
cleavage site, specific initiation of transcription on the SspI-
cleaved template should result in products that are corre-
spondingly larger than those observed with the DraIII-
cleaved template. Transcription of both templates produced
two prominent transcripts whose sizes were appropriately
shifted and, in each case, consistent with transcription
initiation at sites within the HindIII-XbaI insert (Fig. 6A).
The fidelity of transcription in vitro was further examined by
primer extension analysis of nonradioactive products de-
rived from the SspI-cleaved template. Figure 6B, lane 2,
shows the familiar pattern of 5' ends obtained with GP6TB
poly(A)+ RNA when the RT1 primer was used. Comparison
of extension products obtained with the in vitro transcription
1 2 3
FIG. 6. Transcription in vitro of TGFa-pBluescript vectors. (A)
The HindIII-XbaI fragment from the S'-flanking region (see Fig. 4B)
was subcloned into pBluescript, and the resulting plasmid was
cleaved with either SspI or DraIII. Linearized plasmid was tran-
scribed in vitro in the presence of nuclear extract derived from
HeLa cells, and products were analyzed on a 4% acrylamide-urea
gel as described in Materials and Methods. The migration of
HaeIII-cut +X174 markers is shown, and the positions of prominent
transcription products are marked by arrows. (B) Primer extension
analysis of in vitro products. End-labeled RT1 primer was hybrid-
ized to 10 p.g of poly(A)+ RNA from rat liver or GP6TB cells or the
products of an in vitro transcription and treated as described in Fig.
4C and Materials and Methods. The migration of Hinfl-cut pBR322
markers is shown. bp, Base pairs.
products (lane 3) revealed an identical pattern of predomi-
nant bands, as well as some minor products. With a longer
exposure of the autoradiogram shown in Fig. 6B, all of the
minor bands that were obtained with endogenous TGFa
transcripts could also be detected with the in vitro tran-
scripts (data not shown).
Taken together, the results of the transient-expression and
in vitro transcription assays indicate that the genomic se-
quences that flank the mRNA 5' ends include the TGFa
promoter and suggest that the multiple 5' ends are the result
of heterogeneous initiation of transcription at this promoter.
Despite the apparent difference in the number of transcrip-
tion start sites, these data are consistent with the report that
the analogous human sequences also contain promoterlike
activity as demonstrated by transient-expression assays (17).
Characterization of the TGFa 5'-flanking sequences. The
nucleotide sequence of a 650-base-pair region that precedes
the translational initiation codon was determined and is
shown in Fig. 7. This region demonstrates a high G+C
content (70%) that is especially marked in the 3' portion,
which includes the various transcription start sites. In addi-
tion, it contains three potential SPl-binding sites, several
imperfect indirect repeats, and elements of potential AP2-
binding sites. However, this region is most notable for its
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FIG. 7. Nucleotide sequence of the rat TGFa promoter region. Sequence is numbered relative to the first nucleotide of the initiating codon.
The 5' ends of six independently cloned cDNAs are marked ( V ). The 5'-most cDNA was isolated from a library whose synthesis had been
primed with an oligonucleotide that was complementary to a portion of the 5' untranslated region directly upstream from the initiation codon.
The 5' ends of endogenous TGFa mRNA as revealed by primer extension (*) or S1 nuclease analysis (@) are shown, and two prominent
transcription start sites are boxed. Potential SPl-binding sites are underlined, and the locations of several restriction enzyme recognition sites
are indicated (note that the locations of two additional, 3'-distal BssHII sites are not shown). The nucleotide sequence of intron 1 is designated
by lowercase letters. This sequence will appear in the EMBL, GenBank, and DDBJ nucleotide sequence data bases under the accession
number M31075.
or TATA boxes. This latter fact may be consistent with the
extreme heterogeneity of transcriptional initiation, since the
TATA box is generally believed to direct RNA polymerase
II to a defined start position (19). Thus, heterogeneous
initiation in the absence of an obvious TATA element is a
characteristic which the rat TGFa promoter shares with a
large number of other promoters, including that of the
human epidermal growth factor receptor gene (16). It is
surprising, therefore, that the human TGFa promoter was
recently reported to direct transcription from a single start
site. This species difference may be explained, in part, by the
finding that although the rat and human 5'-flanking se-
quences are highly conserved (Fig. 7) (17), the human
sequence nevertheless contains a larger number of potential
SPl-binding sites. However, that these sites are, indeed,
bound by SP1 has not yet been established.
Another notable feature of the rat TGFa promoter is the
apparent absence of other transcriptional regulatory ele-
ments. Thus, although expression of TGFa mRNA is regu-
lated by estrogens and TPA in several cell lines and tissues,
the 5'-flanking region shown in Fig. 7 does not appear to
contain recognizable estrogen-responsive (23) or TPA-re-
sponsive (35, 42) elements. This latter fact, together with the
finding that the TPA induction of TGFa mRNA in GP6ac
cells is distinct from that of c-myc and c-fos, in terms of both
the time course and sensitivity to protein synthesis inhibi-
tors, suggests that regulation of TGFa mRNA by these
agents may be indirectly mediated by other activities.
Whether this hypothesis is correct or, instead, the respon-
sive elements for these agents reside elsewhere in the gene
has yet to be determined. The cloning and characterization
of the rat gene and its promoter, as described here, provide
valuable tools with which to dissect the molecular regulation
of this gene.
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